Piramal may sell contract pharma business for $1 bn: Reports
Billionaire Ajay Piramal-led Piramal Enterprises is considering the sale of its contract pharmaceutical business, which could reportedly fetch about $1 billion. The sale of the unit, known as Piramal Pharma Solutions, has attracted interest from private equity firms and US companies, reports said. In 2010, the company sold its domestic formulations business to Abbott Laboratories for $3.7 billion.